back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-23 14:06 Tx date 2023-03-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$974.91
+300 vol $3.25 each |
25,500 | |
| Filed 2023-03-23 14:06 Tx date 2023-03-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$648.02
+200 vol $3.24 each |
25,200 | |
| Filed 2022-05-26 13:46 Tx date 2022-05-22 |
$TRYP
Tryp Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,000
+200,000 vol $0.17 each |
600,000 | |
| Filed 2022-04-26 13:38 Tx date 2022-04-22 |
$TRYP
Tryp Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-200,000 vol |
400,000 | |
| Filed 2022-04-25 13:56 Tx date 2022-04-22 |
$TRYP
Tryp Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,000
+400,000 vol $0.17 each |
600,000 | |
| Filed 2021-11-12 16:43 Tx date 2021-11-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,500
+25,000 vol $1.50 each |
25,000 | |
| Filed 2021-11-12 16:42 Tx date 2021-11-12 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
51 - Exercise of options
|
$-37,500
-25,000 vol $1.50 each |
35,000 | |
| Filed 2021-04-01 19:19 Tx date 2021-04-01 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$136,000
+200,000 vol $0.68 each |
200,000 | |
| Filed 2021-04-01 19:18 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-13 17:25 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+6,000,000 vol |
6,000,000 | |
| Filed 2020-12-15 13:48 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+6,000,000 vol |
||
| Filed 2021-01-08 10:58 Tx date 2021-01-06 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+5,000 vol |
60,000 | |
| Filed 2021-01-08 10:31 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-220,000 vol |
55,000 | |
| Filed 2020-12-15 13:48 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+6,000,000 vol |
6,000,000 | |
| Filed 2020-12-15 13:47 Tx date 2019-09-24 |
$TRYP
TRYP Therapeutics Inc. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-24 19:32 Tx date 2020-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,000
-25,000 vol $1.40 each |
0 | |
| Filed 2020-08-20 12:19 Tx date 2020-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,500
+25,000 vol $0.30 each |
25,000 | |
| Filed 2020-08-20 12:18 Tx date 2020-08-17 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
51 - Exercise of options
|
$-7,500
-25,000 vol $0.30 each |
275,000 | |
| Filed 2020-08-19 18:57 Tx date 2016-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-02 Tx date 2018-12-31 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$150,000
+150,000 vol $1.00 each |
300,000 | |
| Filed 2017-01-09 Tx date 2016-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2017-01-09 Tx date 2016-12-29 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Kuo, James
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|